170 related articles for article (PubMed ID: 26078709)
1. Pim-2 Modulates Aerobic Glycolysis and Energy Production during the Development of Colorectal Tumors.
Zhang XH; Yu HL; Wang FJ; Han YL; Yang WL
Int J Med Sci; 2015; 12(6):487-93. PubMed ID: 26078709
[TBL] [Abstract][Full Text] [Related]
2. Pim-3 promotes human pancreatic cancer growth by regulating tumor vasculogenesis.
Liu B; Wang Z; Li HY; Zhang B; Ping B; Li YY
Oncol Rep; 2014 Jun; 31(6):2625-34. PubMed ID: 24789328
[TBL] [Abstract][Full Text] [Related]
3. PIM kinases: an overview in tumors and recent advances in pancreatic cancer.
Xu J; Zhang T; Wang T; You L; Zhao Y
Future Oncol; 2014 Apr; 10(5):865-76. PubMed ID: 24799066
[TBL] [Abstract][Full Text] [Related]
4. Pim-3, a proto-oncogene with serine/threonine kinase activity, is aberrantly expressed in human pancreatic cancer and phosphorylates bad to block bad-mediated apoptosis in human pancreatic cancer cell lines.
Li YY; Popivanova BK; Nagai Y; Ishikura H; Fujii C; Mukaida N
Cancer Res; 2006 Jul; 66(13):6741-7. PubMed ID: 16818649
[TBL] [Abstract][Full Text] [Related]
5. STK25-induced inhibition of aerobic glycolysis via GOLPH3-mTOR pathway suppresses cell proliferation in colorectal cancer.
Wu F; Gao P; Wu W; Wang Z; Yang J; Di J; Jiang B; Su X
J Exp Clin Cancer Res; 2018 Jul; 37(1):144. PubMed ID: 29996891
[TBL] [Abstract][Full Text] [Related]
6. Interleukin-6 stimulates aerobic glycolysis by regulating PFKFB3 at early stage of colorectal cancer.
Han J; Meng Q; Xi Q; Zhang Y; Zhuang Q; Han Y; Jiang Y; Ding Q; Wu G
Int J Oncol; 2016 Jan; 48(1):215-24. PubMed ID: 26530697
[TBL] [Abstract][Full Text] [Related]
7. Essential contribution of Ets-1 to constitutive Pim-3 expression in human pancreatic cancer cells.
Li YY; Wu Y; Tsuneyama K; Baba T; Mukaida N
Cancer Sci; 2009 Mar; 100(3):396-404. PubMed ID: 19154409
[TBL] [Abstract][Full Text] [Related]
8. The ubiquitination ligase SMURF2 reduces aerobic glycolysis and colorectal cancer cell proliferation by promoting ChREBP ubiquitination and degradation.
Li Y; Yang D; Tian N; Zhang P; Zhu Y; Meng J; Feng M; Lu Y; Liu Q; Tong L; Hu L; Zhang L; Yang JY; Wu L; Tong X
J Biol Chem; 2019 Oct; 294(40):14745-14756. PubMed ID: 31409643
[TBL] [Abstract][Full Text] [Related]
9. Antisense oligodeoxynucleotides targeting the serine/threonine kinase Pim-2 inhibited proliferation of DU-145 cells.
Dai JM; Zhang SQ; Zhang W; Lin RX; Ji ZZ; Wang SQ
Acta Pharmacol Sin; 2005 Mar; 26(3):364-8. PubMed ID: 15715935
[TBL] [Abstract][Full Text] [Related]
10. The PIM-1 serine kinase prolongs survival and inhibits apoptosis-related mitochondrial dysfunction in part through a bcl-2-dependent pathway.
Lilly M; Sandholm J; Cooper JJ; Koskinen PJ; Kraft A
Oncogene; 1999 Jul; 18(27):4022-31. PubMed ID: 10435626
[TBL] [Abstract][Full Text] [Related]
11. Pim-2 upregulation: biological implications associated with disease progression and perinueral invasion in prostate cancer.
Dai H; Li R; Wheeler T; Diaz de Vivar A; Frolov A; Tahir S; Agoulnik I; Thompson T; Rowley D; Ayala G
Prostate; 2005 Nov; 65(3):276-86. PubMed ID: 16015593
[TBL] [Abstract][Full Text] [Related]
12. The sweet trap in tumors: aerobic glycolysis and potential targets for therapy.
Yu L; Chen X; Wang L; Chen S
Oncotarget; 2016 Jun; 7(25):38908-38926. PubMed ID: 26918353
[TBL] [Abstract][Full Text] [Related]
13. pim-1 proto-oncogene expression in anti-CD3-mediated T cell activation is associated with protein kinase C activation and is independent of Raf-1.
Wingett D; Long A; Kelleher D; Magnuson NS
J Immunol; 1996 Jan; 156(2):549-57. PubMed ID: 8543805
[TBL] [Abstract][Full Text] [Related]
14. Caveolin-1 increases aerobic glycolysis in colorectal cancers by stimulating HMGA1-mediated GLUT3 transcription.
Ha TK; Her NG; Lee MG; Ryu BK; Lee JH; Han J; Jeong SI; Kang MJ; Kim NH; Kim HJ; Chi SG
Cancer Res; 2012 Aug; 72(16):4097-109. PubMed ID: 22706202
[TBL] [Abstract][Full Text] [Related]
15. Serine/threonine kinase Pim-2 promotes liver tumorigenesis induction through mediating survival and preventing apoptosis of liver cell.
Gong J; Wang J; Ren K; Liu C; Li B; Shi Y
J Surg Res; 2009 May; 153(1):17-22. PubMed ID: 18675992
[TBL] [Abstract][Full Text] [Related]
16. A novel regulatory mechanism of Pim-3 kinase stability and its involvement in pancreatic cancer progression.
Zhang F; Liu B; Wang Z; Yu XJ; Ni QX; Yang WT; Mukaida N; Li YY
Mol Cancer Res; 2013 Dec; 11(12):1508-20. PubMed ID: 24165482
[TBL] [Abstract][Full Text] [Related]
17. Efficient inhibition of human colorectal carcinoma growth by RNA interference targeting polo-like kinase 1 in vitro and in vivo.
Xu WJ; Zhang S; Yang Y; Zhang N; Wang W; Liu SY; Tian HW; Dai L; Xie Q; Zhao X; Wei YQ; Deng HX
Cancer Biother Radiopharm; 2011 Aug; 26(4):427-36. PubMed ID: 21797676
[TBL] [Abstract][Full Text] [Related]
18. Targeting PIM kinases impairs survival of hematopoietic cells transformed by kinase inhibitor-sensitive and kinase inhibitor-resistant forms of Fms-like tyrosine kinase 3 and BCR/ABL.
Adam M; Pogacic V; Bendit M; Chappuis R; Nawijn MC; Duyster J; Fox CJ; Thompson CB; Cools J; Schwaller J
Cancer Res; 2006 Apr; 66(7):3828-35. PubMed ID: 16585210
[TBL] [Abstract][Full Text] [Related]
19. Klotho negatively regulated aerobic glycolysis in colorectal cancer via ERK/HIF1α axis.
Li Q; Li Y; Liang L; Li J; Luo D; Liu Q; Cai S; Li X
Cell Commun Signal; 2018 Jun; 16(1):26. PubMed ID: 29884183
[TBL] [Abstract][Full Text] [Related]
20. Expression of Pim-3 in colorectal cancer and its relationship with prognosis.
Zhou Z; Zhang R; Wang R; Zhang Y; Xu L; Chen J; Zhang J; Huang Z; Chen M; Pan Z
Tumour Biol; 2016 Jul; 37(7):9151-6. PubMed ID: 26768612
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]